Clinical aspects of hypertensive myocardial fibrosis - PubMed (original) (raw)
Review
Clinical aspects of hypertensive myocardial fibrosis
J Díez et al. Curr Opin Cardiol. 2001 Nov.
Free article
Abstract
Myocardial fibrosis is one of the histologic constituents of myocardial remodeling present in hypertensive patients with hypertensive heart disease. In fact, an exaggerated interstitial and perivascular accumulation of fibrillar collagens type I and type III has been found in the myocardium of patients with arterial hypertension and left ventricular hypertrophy. Hypertensive myocardial fibrosis has been shown to facilitate abnormalities of cardiac function, coronary reserve, and electrical activity that adversely affect the clinical outcome of hypertensive patients. Therefore, development of noninvasive tools for the monitoring of myocardial fibrosis and pharmacological strategies aimed to promote the regression of fibrosis could be of particular relevance in the clinical treatment of patients with hypertensive heart disease.
Similar articles
- [Altered fibrillar collagen metabolism in hypertensive heart failure. Current understanding and future prospects].
López Salazar B, Ravassa Albéniz S, Arias Guedón T, González Miqueo A, Querejeta R, Díez Martínez J. López Salazar B, et al. Rev Esp Cardiol. 2006 Oct;59(10):1047-57. doi: 10.1157/13093982. Rev Esp Cardiol. 2006. PMID: 17125715 Review. Spanish. - Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease.
Díez J. Díez J. Circ J. 2008;72 Suppl A:A8-12. doi: 10.1253/circj.cj-07-1067. Epub 2008 Sep 4. Circ J. 2008. PMID: 18772529 Review. - Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease.
Weber KT, Sun Y, Gerling IC, Guntaka RV. Weber KT, et al. Am J Hypertens. 2017 Nov 1;30(11):1049-1052. doi: 10.1093/ajh/hpx054. Am J Hypertens. 2017. PMID: 28379281 Review. - Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.
Motz W, Strauer BE. Motz W, et al. J Cardiovasc Pharmacol. 1994;24 Suppl 1:S34-8. doi: 10.1097/00005344-199424001-00007. J Cardiovasc Pharmacol. 1994. PMID: 7533225 Review. - Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management.
González A, López B, Ravassa S, San José G, Latasa I, Butler J, Díez J. González A, et al. Hypertension. 2024 Feb;81(2):218-228. doi: 10.1161/HYPERTENSIONAHA.123.21708. Epub 2023 Dec 12. Hypertension. 2024. PMID: 38084597 Review.
Cited by
- Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension.
Chu HW, Hwang IC, Kim HM, Park J, Choi H, Choi HM, Yoon YE, Cho GY. Chu HW, et al. Hypertens Res. 2024 May;47(5):1144-1156. doi: 10.1038/s41440-023-01571-w. Epub 2024 Jan 18. Hypertens Res. 2024. PMID: 38238511 - Fragmented QRS in inferior leads is associated with non-alcholic fatty liver disease, body-mass index, and interventricular septum thickness in young men.
Sarıkaya R, Şengül C, Kümet Ö, İmre G, Akbulut T, Oğuz M. Sarıkaya R, et al. Anatol J Cardiol. 2022 Feb;26(2):100-104. doi: 10.5152/AnatolJCardiol.2021.433. Anatol J Cardiol. 2022. PMID: 35190357 Free PMC article. - Tanshinone IIA Improves Ventricular Remodeling following Cardiac Infarction by Regulating miR-205-3p.
Qiao P, Xu J, Liu X, Li X. Qiao P, et al. Dis Markers. 2021 Nov 29;2021:8740831. doi: 10.1155/2021/8740831. eCollection 2021. Dis Markers. 2021. PMID: 34880957 Free PMC article. - Prevalence and risk factors of atrioventricular block among 15 million Chinese health examination participants in 2018: a nation-wide cross-sectional study.
Shan R, Ning Y, Ma Y, Liu S, Wu J, Fan X, Lv J, Wang B, Li S, Li L. Shan R, et al. BMC Cardiovasc Disord. 2021 Jun 11;21(1):289. doi: 10.1186/s12872-021-02105-3. BMC Cardiovasc Disord. 2021. PMID: 34116630 Free PMC article. - Catheter-Based Radiofrequency Renal Sympathetic Denervation Decreases Left Ventricular Hypertrophy in Hypertensive Dogs.
Tu S, Shen ZJ, Wang XY, Zeng LX, Zhang ZH. Tu S, et al. Mediators Inflamm. 2021 Apr 24;2021:9938486. doi: 10.1155/2021/9938486. eCollection 2021. Mediators Inflamm. 2021. PMID: 33986629 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical